Moffitt Cancer Center researchers created machine learning models that use patient-reported outcomes and wearable data to predict urgent care visits for non-small cell lung cancer patients.
Key Details
- 1Machine learning models incorporated wearable sensor data (Fitbit) and quality-of-life surveys from 58 non–small cell lung cancer patients.
- 2Models using patient-reported and wearable data outperformed those using only clinical/demographic data in predicting urgent care visits during systemic therapy.
- 3Researchers employed explainable Bayesian Networks, revealing how symptom, sleep, and lab data affect risk.
- 4Study highlights potential to proactively intervene and prevent hospitalizations due to treatment complications.
- 5This was a single-center study with a modest sample; larger validation is planned.
Why It Matters
Integrating diverse patient-originated health data with explainable AI models could transform personalized cancer care by allowing real-time identification of high-risk patients and early intervention, potentially preventing costly or harmful acute events. Such approaches expand the role of AI in predictive analytics for oncology.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.